Lomotil and Thalidomide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lomotil (atropine sulfate; diphenoxylate hydrochloride) and Thalidomide (thalidomide). Common drug interactions include lymphopenia among females and bone disorder among males.

The phase IV clinical study analyzes what interactions people have when they take Lomotil and Thalidomide. It is created by eHealthMe based on reports of 57 people who take the same drugs from the FDA, and is updated regularly.

What is Lomotil?

Lomotil has active ingredients of atropine sulfate; diphenoxylate hydrochloride. It is often used in diarrhea. eHealthMe is studying from 19,184 Lomotil users. Check the latest studies of Lomotil.

What is Thalidomide?

Thalidomide has active ingredients of thalidomide. eHealthMe is studying from 16,473 Thalidomide users. Check the latest studies of Thalidomide.



On Jul, 24, 2026

57 people who take Lomotil and Thalidomide together, and have interactions are studied.

Lomotil and Thalidomide drug interactions.

What are the common drug interactions of Lomotil and Thalidomide, by gender? *:

female:

  1. Lymphopenia (an abnormally low level of lymphocytes in the blood)
  2. Nausea (feeling of having an urge to vomit)
  3. Neutropenia (an abnormally low number of neutrophils)
  4. Thrombocytopenia (decrease of platelets in blood)
  5. Weight decreased
  6. Cushingoid (obesity and weakening of the muscles)
  7. Gastric haemorrhage (bleeding stomach)
  8. Haemoglobin decreased
  9. Leukopenia (less number of white blood cells in blood)

male:

  1. Bone disorder
  2. Depression
  3. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  4. Hypoaesthesia (reduced sense of touch or sensation)
  5. Dizziness
  6. Multiple myeloma (cancer of the plasma cells)
  7. Chest pain
  8. Arthralgia (joint pain)
  9. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  10. Spinal osteoarthritis (joint cartilage loss in spine)

What are the common drug interactions of Lomotil and Thalidomide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Renal failure (kidney dysfunction)
  2. Back pain
  3. Bone disorder
  4. Compression fracture (fracture due to pressure caused by injury)
  5. Fatigue (feeling of tiredness)
  6. Gait disturbance
  7. Osteonecrosis of jaw (death of bone of jaw)
  8. Tooth extraction
  9. Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood)
  10. Pneumonia

60+:

  1. Bone disorder
  2. Depression
  3. Haemorrhoids (a swollen vein or group of veins in the region of the anus)
  4. Hypoaesthesia (reduced sense of touch or sensation)
  5. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  6. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  7. Syncope (loss of consciousness with an inability to maintain postural tone)
  8. Toothache (tooth pain)
  9. Cough
  10. Osteonecrosis of jaw (death of bone of jaw)

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 48 people, 84.21%
  2. High Blood Pressure: 26 people, 45.61%
  3. Seborrhoeic Dermatitis (a common, inflammatory skin condition that causes flaky, white to yellowish scales to form on oily areas such as the scalp): 25 people, 43.86%
  4. Mood Swings (an extreme or rapid change in mood): 25 people, 43.86%
  5. Joint Pain: 25 people, 43.86%
  6. High Blood Cholesterol: 25 people, 43.86%
  7. Fluid Retention (an abnormal accumulation of fluid in the blood): 25 people, 43.86%
  8. Seasonal Allergy (allergic condition due to certain season): 18 people, 31.58%
  9. Blood Triglycerides Decreased: 18 people, 31.58%

* Approximation only. Some reports may have incomplete information.

Do you take Lomotil and Thalidomide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lomotil and Thalidomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lomotil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Thalidomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lomotil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Thalidomide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on atropine sulfate; diphenoxylate hydrochloride and thalidomide (the active ingredients of Lomotil and Thalidomide, respectively), and Lomotil and Thalidomide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: